Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 38

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 38
---
 our Annual Report on Form 10-K for the year ended December 31, 2024, which is incorporated
by reference into this prospectus and elsewhere in the registration statement of which this prospectus is a part. Our financial statements
are incorporated by reference in reliance on RBSM LLP’s report, given on their authority as experts in accounting and auditing.

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

We file annual, quarterly and special reports,
proxy statements and other information with the SEC. You can inspect and copy these reports, proxy statements and other information at
the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further
information on the Public Reference Room. The SEC also maintains a web site that contains reports, proxy and information statements and
other information regarding issuers, such as ENDRA Life Sciences Inc. (www.sec.gov). Our web site is located at www.endrainc.com. The
information contained on, or that may be obtained from, our website is not, and shall not be deemed to be, a part of this prospectus.

We will provide, upon written or oral request,
without charge to you, including any beneficial owner to whom this prospectus is delivered, a copy of any or all of the documents incorporated
herein by reference other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the
information that this prospectus incorporates. You should direct a request for copies to ENDRA Life Sciences Inc., 3600 Green Court, Suite
350, Ann Arbor, Michigan 48105; Telephone: (734) 335-0468.

<div align='center'>S-23

INCORPORATION BY REFERENCE</div>

The SEC allows us to “incorporate by reference”
information from other documents that we file with it, which means that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is considered to be part of this prospectus. Information in this prospectus
supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus.

We incorporate by reference into this prospectus
and the registration statement of which this prospectus is a part the information or documents listed below that we have filed with the
SEC:

| ● | The description of the Company’s common stock contained in